449 related articles for article (PubMed ID: 32166821)
1. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy.
Torphy RJ; Schulick RD; Zhu Y
Mol Carcinog; 2020 Jul; 59(7):775-782. PubMed ID: 32166821
[TBL] [Abstract][Full Text] [Related]
2. An Immunological Glance on Pancreatic Ductal Adenocarcinoma.
Melzer MK; Arnold F; Stifter K; Zengerling F; Azoitei N; Seufferlein T; Bolenz C; Kleger A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397303
[TBL] [Abstract][Full Text] [Related]
3. Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.
Wu J; Cai J
Dig Dis Sci; 2021 Feb; 66(2):359-368. PubMed ID: 32140943
[TBL] [Abstract][Full Text] [Related]
4. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
Fan JQ; Wang MF; Chen HL; Shang D; Das JK; Song J
Mol Cancer; 2020 Feb; 19(1):32. PubMed ID: 32061257
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of pancreatic cancer.
Sunami Y; Kleeff J
Prog Mol Biol Transl Sci; 2019; 164():189-216. PubMed ID: 31383405
[TBL] [Abstract][Full Text] [Related]
6. Advances in immunotherapy for pancreatic ductal adenocarcinoma.
Miyazawa M; Katsuda M; Kawai M; Hirono S; Okada KI; Kitahata Y; Yamaue H
J Hepatobiliary Pancreat Sci; 2021 May; 28(5):419-430. PubMed ID: 33742512
[TBL] [Abstract][Full Text] [Related]
7. Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
Hilmi M; Bartholin L; Neuzillet C
World J Gastroenterol; 2018 May; 24(20):2137-2151. PubMed ID: 29853732
[TBL] [Abstract][Full Text] [Related]
8. Emerging trends in the immunotherapy of pancreatic cancer.
Banerjee K; Kumar S; Ross KA; Gautam S; Poelaert B; Nasser MW; Aithal A; Bhatia R; Wannemuehler MJ; Narasimhan B; Solheim JC; Batra SK; Jain M
Cancer Lett; 2018 Mar; 417():35-46. PubMed ID: 29242097
[TBL] [Abstract][Full Text] [Related]
9. Challenges and Opportunities for Pancreatic Cancer Immunotherapy.
Bear AS; Vonderheide RH; O'Hara MH
Cancer Cell; 2020 Dec; 38(6):788-802. PubMed ID: 32946773
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for pancreatic cancer: present and future.
Aroldi F; Zaniboni A
Immunotherapy; 2017 Jun; 9(7):607-616. PubMed ID: 28595517
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment.
Looi CK; Chung FF; Leong CO; Wong SF; Rosli R; Mai CW
J Exp Clin Cancer Res; 2019 Apr; 38(1):162. PubMed ID: 30987642
[TBL] [Abstract][Full Text] [Related]
12. Strategies to relieve immunosuppression in pancreatic cancer.
Schnurr M; Duewell P; Bauer C; Rothenfusser S; Lauber K; Endres S; Kobold S
Immunotherapy; 2015; 7(4):363-76. PubMed ID: 25917628
[TBL] [Abstract][Full Text] [Related]
13. Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer.
Mortezaee K
J Biochem Mol Toxicol; 2021 Apr; 35(4):e22708. PubMed ID: 33491255
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel.
Brouwer TP; Vahrmeijer AL; de Miranda NFCC
Cell Oncol (Dordr); 2021 Apr; 44(2):261-278. PubMed ID: 33710604
[TBL] [Abstract][Full Text] [Related]
15. Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.
Blair AB; Zheng L
Chin Clin Oncol; 2017 Jun; 6(3):31. PubMed ID: 28705008
[TBL] [Abstract][Full Text] [Related]
16. CD40 immunotherapy for pancreatic cancer.
Vonderheide RH; Bajor DL; Winograd R; Evans RA; Bayne LJ; Beatty GL
Cancer Immunol Immunother; 2013 May; 62(5):949-54. PubMed ID: 23589109
[TBL] [Abstract][Full Text] [Related]
17. Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness.
Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Marchesi F
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1219-28. PubMed ID: 25222571
[TBL] [Abstract][Full Text] [Related]
18. Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma.
Pandey V; Storz P
Expert Rev Anticancer Ther; 2019 Jun; 19(6):473-482. PubMed ID: 31148495
[No Abstract] [Full Text] [Related]
19. Current Status of Immunotherapies for Treating Pancreatic Cancer.
Wu AA; Jaffee E; Lee V
Curr Oncol Rep; 2019 May; 21(7):60. PubMed ID: 31101991
[TBL] [Abstract][Full Text] [Related]
20. Current and future immunotherapeutic approaches in pancreatic cancer treatment.
Farhangnia P; Khorramdelazad H; Nickho H; Delbandi AA
J Hematol Oncol; 2024 Jun; 17(1):40. PubMed ID: 38835055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
